Cite
HARVARD Citation
Kaplan, A. et al. (2020). Long-Term Infectious and Noninfectious Outcomes of Monthly Alemtuzumab as a Calcineurin Inhibitor- and Steroid-Free Regimen for Pancreas Transplant Recipients. Canadian journal of infectious diseases & medical microbiology =. p. . [Online].